Expediting the chromatographic analysis of COVID-19 antibody therapeutics with ultra-short columns, retention modeling and automated method developmentArticle Published on 2022-11-302022-11-15 Journal: Journal of pharmaceutical and biomedical analysis [Category] [DOI] 10.1016/j.jpba.2022.115039 PMC 바로가기
Characterization of Casirivimab Plus Imdevimab, Sotrovimab, and Bamlanivimab Plus Etesevimab-Derived Interference in Serum Protein Electrophoresis and Immunofixation ElectrophoresisArticle Published on 2022-10-292022-11-15 Journal: The journal of applied laboratory medicine [Category] [DOI] 10.1093/jalm/jfac064 PMC 바로가기
Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants중증급성호흡기증후군 코로나바이러스 2 델타 및 오미크론 변이체에 대한 단일클론항체의 임상적 효능 및 시험관내 중화능Article Published on 2022-10-012022-09-11 Journal: Journal of medical virology [Category] [DOI] 10.1002/jmv.27916 PMC 바로가기 [Article Type] Article
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2SARS-CoV-2 Omicron subvariants, BA.1 및 BA.2에 대한 중화 항체 및 항바이러스 약물의 다양한 효능Article Published on 2022-09-012022-09-11 Journal: Antiviral Research [Category] [DOI] 10.1016/j.antiviral.2022.105372 PMC 바로가기 [Article Type] Article
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19Randomized Controlled Trial Published on 2022-09-012022-10-04 Journal: International Journal of Infectious Diseases [Category] [DOI] 10.1016/j.ijid.2022.06.045 PMC 바로가기 [Article Type] Randomized Controlled Trial
Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19Case report Published on 2022-09-012022-10-05 Journal: JAAD Case Reports [Category] [DOI] 10.1016/j.jdcr.2022.07.007 [Article Type] Case report
Clinical efficacy of casirivimab-imdevimab antibody combination treatment in patients with COVID-19 Delta variant코로나19 델타 변이형 환자에서 카시리비맙-임데비맙 항체 병용요법의 임상적 효능Article Published on 2022-09-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] [DOI] 10.1016/j.jiac.2022.05.012 PMC 바로가기 [Article Type] Article
Evolution of Anti-SARS-CoV-2 Therapeutic AntibodiesArticle Published on 2022-08-282022-11-15 Journal: International Journal of Molecular Sciences [Category] [DOI] 10.3390/ijms23179763 PMC 바로가기
Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders코로나바이러스 2019(COVID-19) 및 면역결핍 관련 항체 장애 환자에서 REGEN-COV®의 자비로운 사용Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] [DOI] 10.1093/cid/ciab1059 PMC 바로가기 [Article Type] Article
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particlesOmicron 돌연변이는 SARS-CoV-2 바이러스 유사 입자의 감염성을 높이고 항체 중화를 감소시킵니다.Article Published on 2022-08-022022-09-11 Journal: Proceedings of the National Academy of Sciences of [Category] [DOI] 10.1073/pnas.2200592119 PMC 바로가기 [Article Type] Article